福瑞达(600223) - 2021 Q4 - 年度财报

Financial Performance - The company achieved a net profit attributable to shareholders of 361,900,881.01 RMB for the year 2021, with the parent company reporting a net profit of 351,504,529.99 RMB[6]. - The company's operating revenue for 2021 was approximately ¥12.36 billion, a decrease of 9.20% compared to 2020[27]. - Net profit attributable to shareholders for 2021 was approximately ¥361.90 million, down 43.34% year-on-year[30]. - The total profit for 2021 was 644 million RMB, down 24.58% compared to the previous year[80]. - Net profit attributable to the parent company was 362 million RMB, reflecting a significant decline of 43.34% year-on-year[80]. - The total assets at the end of 2021 were approximately ¥61.42 billion, a slight decrease of 0.14% from the previous year[27]. - The weighted average return on equity for 2021 was 8.34%, a decrease of 11.69 percentage points from 2020[30]. - The basic earnings per share for 2021 was ¥0.36, a decrease of 43.75% compared to 2020[30]. Dividend and Profit Distribution - The proposed cash dividend distribution is 1.1 RMB per 10 shares, totaling 111,006,741.89 RMB, with 303,331,957.80 RMB available for distribution to shareholders[6]. - The company has a remaining undistributed profit of 192,325,215.91 RMB to be carried forward to future years[6]. - The company is committed to sustainable development and shareholder returns as part of its profit distribution strategy[6]. Risk Management and Compliance - The company emphasizes the importance of risk awareness regarding forward-looking statements related to future strategies and financial conditions[7]. - There are no non-operating fund occupations by controlling shareholders or related parties reported[8]. - The company has not violated decision-making procedures for external guarantees[10]. - The board of directors and management have confirmed the accuracy and completeness of the annual report[4]. - The audit report issued by Da Xin Accounting Firm is a standard unqualified opinion[5]. Business Operations and Revenue Streams - The company achieved a contract sales amount of ¥14.645 billion in 2021, a decrease of 16.78% year-on-year, with a sales area of 1.3711 million square meters, down 18.19%[39]. - The company completed new construction of 1.3775 million square meters in 2021, a decrease of 26.78% compared to the previous year[39]. - The company expanded its property management operations, managing approximately 22.87 million square meters by the end of 2021[39]. - The company actively developed light asset businesses, including health care and commercial management, and secured multiple government and market construction projects[39]. Cosmetics and Pharmaceutical Segments - In 2021, the cosmetics business achieved revenue of 1.495 billion yuan, a year-on-year increase of 117.01%[40]. - The medical segment reported revenue of 541 million yuan, reflecting a year-on-year growth of 8.71%[43]. - The raw materials and additives segment generated revenue of 241 million yuan, with a year-on-year increase of 21.96%[43]. - The total revenue for the pharmaceutical group reached 2.181 billion yuan, accounting for 17.64% of the company's total revenue, an increase of 8.03 percentage points from the previous year[43]. - The net profit attributable to the parent company was 180 million yuan, representing 49.68% of the total net profit, a year-on-year growth of 33.05%[43]. Research and Development - The company established three new research centers in collaboration with universities, enhancing its R&D capabilities[49]. - The company has been awarded 197 patents and has undertaken over 30 major national and provincial scientific projects, showcasing its strong R&D strength[75]. - The company has initiated six R&D projects in health real estate, enhancing product quality and competitiveness[113]. - The company completed nearly 300 safety and efficacy evaluations for its raw materials in compliance with new regulations[171]. Market Trends and Strategic Initiatives - The health industry operation sector benefits from China's economic growth, urbanization, and rising consumer income, creating strong demand for property services[53]. - The cosmetics market in China reached a size of CNY 367.8 billion in the first 11 months of 2021, with a growth rate of 15.3%[55]. - The introduction of strong regulatory measures in the cosmetics sector is expected to benefit legitimate companies, enhancing market competitiveness[55]. - The company aims to transform from a real estate developer to a lifestyle service provider, focusing on creating better living experiences[61]. Sales and Marketing - The company's online cosmetic sales increased significantly, with revenue of CNY 1,396,293,394.30, reflecting a 144.84% year-over-year growth[1]. - The brand Yilian achieved sales of over 15 million bottles of its hyaluronic acid moisturizing spray in 2021, ranking first in the category on Tmall and winning the Tmall Golden Makeup Award[159]. - The brand Aier Doctor's four key products accounted for approximately 70% of total sales in 2021, with the new product "Anti-Gravity Water Emulsion" exceeding 10 million in sales within months of launch[161]. - The company plans to continue expanding its direct sales and online presence to enhance revenue growth in the cosmetics segment[93]. Investment and Financing - The company secured strategic investments totaling 738 million yuan, setting a record for state-owned enterprises in Shandong Province[45]. - The total financing amount at the end of the period was RMB 1,939.94 million, with an average financing cost of 9.975%[150]. - The company financed RMB 5.45 billion from non-related parties and RMB 381,400 from related parties during the reporting period, both within the authorized limits set by the shareholders' meeting[150]. Land and Development Projects - The company holds a total of 1,000,000 square meters of land for development across various regions, with a significant portion in Qingdao at 247,793 square meters[139]. - The planned construction area for the projects in Qingdao includes 639,981 square meters, indicating a strong focus on residential and commercial developments[140]. - The company has reported a total of 1,000,000,000 RMB in investments across multiple projects in Qingdao, showcasing its strategic focus on this key market[140].